Jun 8 - Jun 14, 2026

This Week's Biotech Catalysts

All FDA decisions, clinical trial readouts, and key events happening this week.

Total Events

PDUFA Dates

Trial Readouts

Monday

June 811

Jun '26

SNYNFPhase 3$106.5B

Dupilumab Phase 3 Est. Readout

Dupilumab• Lichen Simplex Chronicus138

Jun 2026~Estimated

CT.gov

00%

Past

days

TEVAConference$18.2B

Conference

Jun 8AI-detected

Source

Past

days

RYTMPDUFA$3.8B

NDA✅Approved

FDA PDUFA Date IMCIVREE (priority)

Jun 8Confirmed

SEC

Past

days

GENBConference$1.6B

Conference

Jun 8AI-detected

Source

Past

days

NVSConference$292.6B

Conference Presentation

Jun 8AI-detected

Source

Past

days

GPCRConference$835M

Conference — aleniglipron

Jun 8AI-detected

Source

Past

days

BMEAConference$94M

Conference — icovamenib

Jun 8AI-detected

Source

Jun '26

REGNPhase 2$54.8B

Placebo Phase 2 Est. Readout

Alirocumab• Homozygous Familial Hypercholesterolemia195

Jun 2026~Estimated

CT.gov

00%

Jun '26

UCBJYPhase 3$60.4B

rozanolixizumab Phase 3 Est. Readout

Rozanolixizumab• Generalized Myasthenia Gravis12

Jun 2026~Estimated

CT.gov

00%

Past

days

VVOSOther$23M

?Unknown

Vivos Corporate Update

Jun 8Confirmed

Source

Past

days

SPTXEarnings$901M

?Unknown

Seaport Reports Financial Results

Jun 8Confirmed

Source

Tuesday

June 97

Jun '26

JNJPhase 2$367.0B

✓Positive

Capmatinib Phase 2 Est. Readout

Capmatinib• Carcinoma, Non-Small-Cell Lung57

Jun 2026~Estimated

CT.gov

Past

days

LLYConference$807.9B

✓Positive

Conference

Jun 9AI-detected

Source

Past

days

GLSIEarnings$416M

GLSI Earnings Report

Jun 9Confirmed

Source

Past

days

RAREPDUFA$3.4B

NDA?Unknown

FDA PDUFA Date candidate (priority)

Jun 9Confirmed

SEC

Past

days

ABBVConference$325.1B

Conference

Jun 9AI-detected

Source

Jun '26

NVSPhase 2$292.6B

INE963 Phase 2 Est. Readout

INE963• Uncomplicated Plasmodium Falciparum Malaria327

Jun 2026~Estimated

CT.gov

00%

Jun '26

NVOPhase 3$195.1B

✓Positive

Ziltivekimab B Phase 3 Results Expected

Ziltivekimab B• Cardiovascular Risk6,200

Jun 2026~Estimated

CT.gov

Wednesday

June 105

Past

days

RFLEarnings$39M

RFL Earnings Report

Jun 10Confirmed

Source

Past

days

CELG-RIPDUFA

NDA✓Positive

FDA PDUFA Date drug name (standard)

Jun 10Confirmed

SEC

Past

days

ICLREarnings$11.6B

ICLR Earnings Report

Jun 10Confirmed

Source

Past

days

AFJKEarnings$45M

AFJK Earnings Report

Jun 10Confirmed

Source

Past

days

ANIXEarnings$85M

ANIX Earnings Report

Jun 10Confirmed

Source

Thursday

June 1112

Jun '26

AAPGConference$1.6B

Conference — Olverembatinib

Jun 2026~AI-detected

Source

Past

days

VKTXRegulatory$3.0B

📊Data Released

Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer

Jun 11Confirmed

Source

Jun '26

GSKPhase 3$106.7B

BLU-5937 Phase 3 Est. Readout

BLU-5937• Cough975

Jun 2026~Estimated

CT.gov

00%

Past

days

TLXEarnings$3.2B

TLX Earnings Report

Jun 11Confirmed

Source

Past

days

REPLEarnings$523M

REPL Earnings Report

Jun 11Confirmed

Source

Past

days

ACBEarnings$191M

ACB Earnings Report

Jun 11Confirmed

Source

Jun '26

TKPHFPhase 2$48.7B

TAK-755 Phase 2 Est. Readout

TAK-755• Thrombotic Thrombocytopenic Purpura (TTP)33

Jun 2026~Estimated

CT.gov

00%

Past

days

HCMEarnings$1.8B

HCM Earnings Report

Jun 11Confirmed

Source

Past

days

ENGNEarnings$154M

ENGN Earnings Report

Jun 11Confirmed

Source

Past

days

KALVOther$499M

?Unknown

KalVista Corporate Update

Jun 11Confirmed

Source

Past

days

LEGNConference$6.7B

~Mixed

Conference — LB2501

Jun 11AI-detected

Source

Past

days

NBPEarnings$170M

NBP Earnings Report

Jun 11Confirmed

Source

FridayToday

June 125

Today

BNREarnings$100M

BNR Earnings Report

Jun 12Confirmed

Source

Today

ENLVEarnings$168M

ENLV Earnings Report

Jun 12Confirmed

Source

Today

CLDXConference$1.3B

Conference — barzolvolimab

Jun 12AI-detected

Source

Jun '26

XLOPhase 2$35M

vilastobart (XTX101) Phase 2 Est. Readout

vilastobart (XTX101)• Advanced Solid Tumor136

Jun 2026~Estimated

CT.gov

00%

Jun '26

AZNPhase 2$279.4B

✓Positive

AZD7798 Phase 2 Est. Readout

AZD7798• Crohn's Disease192

Jun 2026~Estimated

CT.gov

Saturday

June 13

No events scheduled

Sunday

June 143

Jun '26

GMABPhase 2$15.3B

Epcoritamab Phase 2 Est. Readout

Lenalidomide• Diffuse Large B-Cell Lymphoma111

Jun 2026~Estimated

CT.gov

00%

Jun '26

GMABPhase 3$15.3B

Lenalidomide Phase 3 Est. Readout

Lenalidomide• Diffuse Large B-Cell Lymphoma1,095

Jun 2026~Estimated

CT.gov

00%

days

KURAConference$496M

Conference Presentation - Ziftomenib

Jun 14AI-detected

Source

Get Weekly Catalyst Alerts

Receive a summary of upcoming biotech catalysts every Monday morning.

Why Track Weekly Biotech Catalysts?

Biotech stocks are driven by binary events - FDA decisions, clinical trial results, and regulatory milestones. Knowing which catalysts are coming this week helps investors prepare for potential volatility and trading opportunities.

Key Events to Watch

PDUFA Dates: FDA target action dates for drug approvals
Clinical Trials: Phase 1, 2, and 3 data readouts
AdCom Meetings: FDA Advisory Committee votes
Conferences: Medical conference presentations

Stay Informed

This page updates automatically as new events are added or outcomes are announced. Bookmark it or sign up for our weekly email digest to never miss an important catalyst.